Skip to content
Disclosery

Trilogy Capital Inc.: ALAB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Trilogy Capital Inc. on ALAB, newest first. How the timeline and the estimate are built.

Trilogy Capital Inc. held 2,750 ALAB shares at 2026-06-30 per its 13F-HR filed 2026-07-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,750 shares
    Change vs previous 13F -3,850 shares

    0.05% of the 13F portfolio, value $1,328,305.

    13F-HR 0001722512-26-000004 filed by Trilogy Capital Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,600 shares
    Change vs previous 13F +1,249 shares

    0.03% of the 13F portfolio, value $723,360.

    13F-HR 0001722512-26-000003 filed by Trilogy Capital Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,351 shares
    Change vs previous 13F +1,650 shares

    0.04% of the 13F portfolio, value $890,192.

    13F-HR 0001722512-26-000001 filed by Trilogy Capital Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,701 shares
    Change vs previous 13F -399 shares

    0.03% of the 13F portfolio, value $724,656.

    13F-HR 0001722512-25-000007 filed by Trilogy Capital Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 4,100 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $370,722.

    13F-HR 0001722512-25-000006 filed by Trilogy Capital Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).